Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05241808 · ClinicalTrials.gov registry record · NA

Girls Can...Move! Testing the Feasibility of a Community-based Physical Activity Intervention for Adolescent Girls

A NA study, sponsored by Deirdre Dlugonski.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT05241808: Completed NA study, sponsored by Deirdre Dlugonski.

NCT05241808 is a NA study that has completed, run by Deirdre Dlugonski. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05241808, a NA study, has completed, sponsored by Deirdre Dlugonski.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The purpose of this research is to learn about how to promote physical activity among adolescent girls by testing the feasibility and initial effectiveness of the Girls Can...Move! intervention. Girls Can...Move! will target each component of physical literacy by providing opportunities for adolescent girls to gain knowledge about their own physical activity level, to explore and practice different types of physical activities, and to learn from active female role models. Female participants (n = 30) from one middle school will be randomly assigned to the Girls Can...Move! intervention group or a control group at a 1:1 ratio. The primary outcome variables, physical activity and physical literacy, will be assessed before and after the 8-week Girls Can...Move! intervention using accelerometers and online surveys.

Primary Outcome

The number of participants enrolled, intervention session attendance (experimental group only), and participant satisfaction with intervention (experimental group only) will be included as feasibility measures.

Interventions

  • BEHAVIORAL Girls Can...Move!

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2021-12-02
Est. Completion 2022-04-26
Phase NA
Deirdre Dlugonski

2 total trials

What the finished NCT05241808 record still lists

NCT05241808 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Girls Can...Move! is the first listed.

NCT05241808 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05241808 about?

NCT05241808 is a clinical study titled "Girls Can...Move! Testing the Feasibility of a Community-based Physical Activity Intervention for Adolescent Girls". The purpose of this research is to learn about how to promote physical activity among adolescent girls by testing the feasibility and initial effectiveness of the Girls Can...Move! intervention. Girls Can...Move! will target each component of physical literacy by providing opportunities for adolesce...

What is the current status of trial NCT05241808?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2021-12-02. Estimated completion is 2022-04-26.

What interventions are being tested in trial NCT05241808?

The interventions under investigation include: Girls Can...Move! (BEHAVIORAL).

Who is sponsoring clinical trial NCT05241808?

This trial is sponsored by Deirdre Dlugonski, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05241808's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05241808, the US trial registry maintained by the National Library of Medicine. NCT05241808 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.